Myomo (MYO) Capital Expenditures Growth (1y) (2018 - 2025)
Myomo (MYO) Capital Expenditures Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -6.52% |
| 10 | Myomo | 73.79 Mn | 54.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 228.30% |
| Jun 30, 2025 | 953.36% |
| Mar 31, 2025 | 1,021.40% |
| Dec 31, 2024 | 2,616.72% |
| Sep 30, 2024 | 492.88% |
| Jun 30, 2024 | 697.20% |
| Mar 31, 2024 | 32.66% |
| Dec 31, 2023 | 835.45% |
| Sep 30, 2023 | 843.04% |
| Jun 30, 2023 | -71.64% |
| Mar 31, 2023 | -9.61% |
| Dec 31, 2022 | -85.86% |
| Sep 30, 2022 | -89.55% |
| Jun 30, 2022 | -74.01% |
| Mar 31, 2022 | 12.12% |
| Dec 31, 2021 | 54.84% |
| Sep 30, 2021 | 144.84% |
| Mar 31, 2021 | 464.72% |
| Dec 31, 2020 | 12.59% |
| Sep 30, 2020 | 567.54% |